Specialized to manufacture oral solid dosage forms, Alcami’s Wilmington, North Carolina site supports preclinical production through commercial launch and supply. Our cGMP manufacturing technologies are arranged in flexible suites to support advanced and complex projects.
Alcami will support your animal health products with precise attention to quality by design and process development. We have experience with over 50 animal health products ranging from concept through commercialization in API manufacturing, oral solid dose, and sterile (liquid and lyophilized) products.
Whether you are looking for an all-inclusive integrated offering or an individualized development or manufacturing service, Alcami has the solution to the complex needs of your product.
The increasing trend of highly potent active pharmaceutical ingredients (HPAPIs) being used in new drug development candidates has created a tremendous demand for high containment development and production capabilities. Learn more about Alcami's HPAPI capabilities.
Balancing HPAPI Control with the Chemistry and Efficiency Needs of a CDMO
Extractables & Leachables 101: The Past, Present, and Future
The Importance of Microbial In-Use Studies
Early Phase Development of Biologics
The Importance of Secondary Packaging
Editorial: The Changing R&D Landscape
Editorial: How to Find Your Secret Source
Editorial: Considerations for Approval of Biosimilars
eBook: Analytical Testing in Drug Development
500Investigational New Drug (IND) Filings
400,000+ft² across our facilities
600 US & EU regulatory filings
Alcami Expands its Sterile Fill-Finish Capacity with Acquisition of TriPharm Services
Alcami Announces Sale of its Weert, Netherlands Facility
Alcami Corporation Expanding Operations in Charleston County
CPhI Japan – 3 / 16 - 3 / 18
CED Life Science – 3 / 17 - 3 / 19
DCAT Week – 3 / 23 - 3 / 26
World Orphan Drug Congress – 4 / 29 - 5 / 1
